OverviewSuggest Edit

Yaoyanshe (药研社) is an AI-based contract research organization. It also provides a clinical research entrance platform Trial.Link that connects drug enterprises, hospitals, researchers, industry practitioners, and patients.

Recent NewsAll News

Latest Updates

Employees (est.) (Jul 2021)37(+9%)
Cybersecurity ratingBMore

Yaoyanshe Financials and Metrics

Summary Metrics

Founding Date


Yaoyanshe total Funding

$42.6 m

Yaoyanshe latest funding size

$42.65 m

Time since last funding

2 years ago

Yaoyanshe investors

Yaoyanshe's latest funding round in August 2019 was reported to be $42.6 m. In total, Yaoyanshe has raised $42.6 m
Show all financial metrics

Yaoyanshe Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Yaoyanshe Online and Social Media Presence

Embed Graph

Yaoyanshe News and Updates

Chinese drug R&D platform Yaoyanshe pockets $86m in Series C+, D

The fresh funds were raised across two rounds in a duration of about eight months. The post Chinese drug R&D platform Yaoyanshe pockets $86m in Series C+, D appeared first on DealStreetAsia.

Yaoyanshe Frequently Asked Questions

  • When was Yaoyanshe founded?

    Yaoyanshe was founded in 2015.

  • How many employees does Yaoyanshe have?

    Yaoyanshe has 37 employees.

  • Who are Yaoyanshe competitors?

    Competitors of Yaoyanshe include BlueClinical, Amarex Clinical Research and DM Clinical Research.